Combined use of a KAT6 inhibitor
TW202635296APending Publication Date: 2026-09-01JIANGSU HENGRUI MEDICINE CO LTD +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141206
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-24
- Filing Date
- 2025-10-23
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001074482_001 
Figure TWG2TA001074482_002
Abstract
The present disclosure provides a combined use of a KAT6 inhibitor. Specifically, the present disclosure relates to the use of a compound represented by formula (I) or a pharmaceutically acceptable salt thereof in combination with the following groups in the preparation of a medicament for treating breast cancer: a) a cyclin-dependent kinase
Need to check novelty before this filing date? Find Prior Art